William Douglas Winkelman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pelvic Organ Prolapse | 6 | 2021 | 134 | 3.390 |
Why?
|
Gynecologic Surgical Procedures | 6 | 2021 | 336 | 2.140 |
Why?
|
Vagina | 4 | 2021 | 825 | 1.660 |
Why?
|
Urinary Bladder, Overactive | 3 | 2023 | 106 | 1.620 |
Why?
|
Suburethral Slings | 3 | 2021 | 76 | 1.610 |
Why?
|
Urinary Incontinence, Stress | 2 | 2021 | 183 | 1.370 |
Why?
|
Urinary Incontinence, Urge | 3 | 2018 | 46 | 1.330 |
Why?
|
Gynecology | 2 | 2022 | 509 | 1.070 |
Why?
|
Uterine Prolapse | 2 | 2021 | 73 | 0.980 |
Why?
|
Patient Satisfaction | 3 | 2021 | 3391 | 0.950 |
Why?
|
Surgical Mesh | 2 | 2019 | 256 | 0.710 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2021 | 454 | 0.690 |
Why?
|
Directive Counseling | 1 | 2020 | 166 | 0.680 |
Why?
|
Emotions | 2 | 2021 | 2657 | 0.660 |
Why?
|
Fecal Incontinence | 1 | 2021 | 240 | 0.640 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 264 | 0.620 |
Why?
|
Reproductive Health Services | 1 | 2018 | 80 | 0.610 |
Why?
|
Surgery, Plastic | 1 | 2022 | 618 | 0.540 |
Why?
|
Calculi | 1 | 2016 | 46 | 0.540 |
Why?
|
Urology | 1 | 2020 | 397 | 0.520 |
Why?
|
Vaginal Diseases | 1 | 2016 | 102 | 0.510 |
Why?
|
Hysterectomy | 1 | 2021 | 927 | 0.500 |
Why?
|
Cryopreservation | 1 | 2018 | 664 | 0.470 |
Why?
|
Preimplantation Diagnosis | 1 | 2015 | 151 | 0.430 |
Why?
|
Perioperative Care | 1 | 2020 | 997 | 0.430 |
Why?
|
Catholicism | 1 | 2012 | 30 | 0.420 |
Why?
|
Cholinergic Antagonists | 2 | 2023 | 165 | 0.410 |
Why?
|
Faculty, Medical | 1 | 2020 | 1182 | 0.410 |
Why?
|
Urinary Incontinence | 1 | 2016 | 494 | 0.400 |
Why?
|
Teratogens | 1 | 2012 | 112 | 0.400 |
Why?
|
Public Opinion | 1 | 2015 | 477 | 0.380 |
Why?
|
Contraceptive Agents | 1 | 2012 | 150 | 0.370 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1638 | 0.360 |
Why?
|
Drugs, Investigational | 1 | 2012 | 214 | 0.350 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3667 | 0.300 |
Why?
|
Infertility, Female | 1 | 2013 | 784 | 0.290 |
Why?
|
Patient Readmission | 1 | 2021 | 3111 | 0.290 |
Why?
|
Spirituality | 1 | 2011 | 405 | 0.290 |
Why?
|
Female | 28 | 2024 | 379592 | 0.280 |
Why?
|
Fetus | 1 | 2013 | 1879 | 0.270 |
Why?
|
Reoperation | 3 | 2021 | 4200 | 0.260 |
Why?
|
Informed Consent | 1 | 2012 | 991 | 0.260 |
Why?
|
Postoperative Complications | 3 | 2021 | 15244 | 0.250 |
Why?
|
Recurrence | 3 | 2021 | 8333 | 0.220 |
Why?
|
Retrospective Studies | 9 | 2022 | 77098 | 0.220 |
Why?
|
Bone and Bones | 1 | 2013 | 2575 | 0.210 |
Why?
|
Aged | 14 | 2023 | 162944 | 0.210 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2024 | 187 | 0.210 |
Why?
|
Sacrum | 2 | 2021 | 289 | 0.210 |
Why?
|
Genetic Testing | 1 | 2015 | 3439 | 0.210 |
Why?
|
Pessaries | 1 | 2021 | 17 | 0.200 |
Why?
|
Humans | 29 | 2024 | 742088 | 0.200 |
Why?
|
Benzhydryl Compounds | 2 | 2018 | 840 | 0.200 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5133 | 0.200 |
Why?
|
Hysterectomy, Vaginal | 1 | 2020 | 37 | 0.190 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 24913 | 0.190 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2024 | 357 | 0.180 |
Why?
|
Middle Aged | 14 | 2021 | 213127 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3915 | 0.180 |
Why?
|
Pelvic Floor | 1 | 2021 | 138 | 0.180 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.180 |
Why?
|
Quality of Life | 3 | 2021 | 12730 | 0.170 |
Why?
|
Urologic Surgical Procedures | 1 | 2021 | 301 | 0.160 |
Why?
|
Nocturia | 1 | 2018 | 19 | 0.160 |
Why?
|
Anal Canal | 1 | 2021 | 376 | 0.160 |
Why?
|
Muscarinic Antagonists | 1 | 2018 | 137 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 365 | 0.150 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.150 |
Why?
|
Neoplasms | 2 | 2018 | 21596 | 0.140 |
Why?
|
Acetaminophen | 1 | 2020 | 544 | 0.140 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3151 | 0.140 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 7901 | 0.130 |
Why?
|
Postoperative Period | 1 | 2020 | 1839 | 0.130 |
Why?
|
Marital Status | 1 | 2017 | 437 | 0.130 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.130 |
Why?
|
Medicare | 2 | 2023 | 6532 | 0.130 |
Why?
|
Pregnancy | 4 | 2022 | 29087 | 0.120 |
Why?
|
Treatment Outcome | 5 | 2021 | 62966 | 0.120 |
Why?
|
Parity | 1 | 2017 | 929 | 0.120 |
Why?
|
Data Collection | 1 | 2023 | 3339 | 0.120 |
Why?
|
Schools, Medical | 1 | 2020 | 878 | 0.110 |
Why?
|
Hysteroscopy | 1 | 2013 | 102 | 0.110 |
Why?
|
Patient Preference | 1 | 2019 | 886 | 0.110 |
Why?
|
Age Factors | 2 | 2021 | 18355 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1237 | 0.100 |
Why?
|
Adult | 9 | 2023 | 213712 | 0.100 |
Why?
|
Incidental Findings | 1 | 2016 | 688 | 0.100 |
Why?
|
Pain Measurement | 1 | 2020 | 3418 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2276 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6483 | 0.090 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2009 | 141 | 0.090 |
Why?
|
Time Factors | 2 | 2021 | 40054 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2370 | 0.080 |
Why?
|
United States | 4 | 2024 | 69693 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39004 | 0.080 |
Why?
|
Male | 8 | 2024 | 349538 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 56350 | 0.080 |
Why?
|
Abortion, Induced | 1 | 2013 | 458 | 0.080 |
Why?
|
Clinical Competence | 1 | 2022 | 4681 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3839 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2018 | 12017 | 0.070 |
Why?
|
Adolescent | 4 | 2021 | 85649 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7716 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4961 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57683 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2018 | 3527 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2009 | 726 | 0.060 |
Why?
|
Orgasm | 1 | 2024 | 64 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2451 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7276 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2020 | 21719 | 0.050 |
Why?
|
Sleep | 1 | 2018 | 4604 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9144 | 0.050 |
Why?
|
Ultrasonography | 1 | 2013 | 5978 | 0.050 |
Why?
|
Laparotomy | 1 | 2021 | 474 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4143 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9305 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29010 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 53187 | 0.040 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 786 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1296 | 0.030 |
Why?
|
Women's Health | 1 | 2024 | 2034 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15530 | 0.030 |
Why?
|
Laparoscopy | 1 | 2021 | 2121 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 400 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9846 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12242 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3548 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 689 | 0.020 |
Why?
|
Collagen Type I | 1 | 2009 | 592 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13403 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1675 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20774 | 0.010 |
Why?
|
Breast | 1 | 2009 | 1958 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5212 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7790 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13029 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 23387 | 0.000 |
Why?
|
Mice | 1 | 2009 | 81045 | 0.000 |
Why?
|
Animals | 1 | 2009 | 168561 | 0.000 |
Why?
|